Our findings, and the association of inflammation markers with ptau and total tau but not Aβ42, support a primary role for inflammation in neurodegeneration, presumed due to AD, which is consistent with preclinical and clinical studies [6, 10, 29]. This evidence concerns the gene MAPT and Alzheimer disease.